1-20 of 23
cd20 antigens
Close
Sort by
Journal Articles

Targeting CD20: teaching an old dog new tricks

Jeff P. Sharman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 273–278.
https://doi.org/10.1182/hematology.2019000031
Published: 2019
Journal Articles

Antibody-based therapies in patients with acute lymphoblastic leukemia

Shira Dinner, Michaela Liedtke
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 9–15.
https://doi.org/10.1182/asheducation-2018.1.9
Published: 2018
Journal Articles

Where to start? Upfront therapy for follicular lymphoma in 2018

John P. Leonard, Loretta J. Nastoupil, Christopher R. Flowers
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 185–188.
https://doi.org/10.1182/asheducation-2018.1.185
Published: 2018
Journal Articles

Current treatment of double hit and double expressor lymphoma

Patrick M. Reagan, Andrew Davies
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 295–297.
https://doi.org/10.1182/asheducation-2017.1.295
Published: 2017
Journal Articles

Novel agents in follicular lymphoma: choosing the best target

Laurie H. Sehn
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 284–292.
https://doi.org/10.1182/asheducation-2016.1.284
Published: 2016
Journal Articles

The use of novel monoclonal antibodies in the treatment of acute lymphoblastic leukemia

Daniel J. DeAngelo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 400–405.
https://doi.org/10.1182/asheducation-2015.1.400
Published: 2015
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015
Journal Articles

Advances in therapies for non-Hodgkin lymphoma in children

Rachel Kobos, William Terry
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 522–528.
https://doi.org/10.1182/asheducation.V2015.1.522.3916185
Published: 2015
Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.
https://doi.org/10.1182/asheducation-2013.1.406
Published: 2013
Journal Articles

Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies

James T. B. Crawley, Marie A. Scully
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 292–299.
https://doi.org/10.1182/asheducation-2013.1.292
Published: 2013
Journal Articles

Novel Antibody-Based Therapies For Acute Lymphoblastic Leukemia

Dieter Hoelzer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 243–249.
https://doi.org/10.1182/asheducation-2011.1.243
Published: 2011
Journal Articles

Evidence-Based Mini-Review: The Role of Alkylating Agents in the Initial Treatment of Chronic Lymphocytic Leukemia Patients with the 11q Deletion

Wei Ding, Alessandra Ferrajoli
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 90–92.
https://doi.org/10.1182/asheducation-2010.1.90
Published: 2010
Journal Articles

Novel Agents for Follicular Lymphoma

John P. Leonard, Peter Martin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 259–264.
https://doi.org/10.1182/asheducation-2010.1.259
Published: 2010
Journal Articles

State-of-the-art treatment of chronic lymphocytic leukemia

Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 440–449.
https://doi.org/10.1182/asheducation-2009.1.440
Published: 2009
Journal Articles

Antibody Therapy in Aggressive Lymphomas

Thomas M. Habermann
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 257–264.
https://doi.org/10.1182/asheducation-2007.1.257
Published: 2007
Journal Articles

Follicular NHL: From Antibodies and Vaccines to Graft-versus-Lymphoma Effects

David G. Maloney
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 226–232.
https://doi.org/10.1182/asheducation-2007.1.226
Published: 2007
Journal Articles

Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

Celeste Bello, Eduardo M. Sotomayor
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 233–242.
https://doi.org/10.1182/asheducation-2007.1.233
Published: 2007
Journal Articles

Targeting CD20 in Follicular NHL: Novel Anti-CD20 Therapies, Antibody Engineering, and the Use of Radioimmunoconjugates

John P. Leonard
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 335–339.
https://doi.org/10.1182/asheducation-2005.1.335
Published: 2005
Journal Articles

Unique Toxicities and Resistance Mechanisms Associated with Monoclonal Antibody Therapy

Jonathan W. Friedberg
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 329–334.
https://doi.org/10.1182/asheducation-2005.1.329
Published: 2005
Journal Articles

Update on Epidemiology and Therapeutics for Non-Hodgkin’s Lymphoma

Julie M. Vose, Brian C.-H. Chiu, Bruce D. Cheson, Janet Dancey, John Wright
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2002) 2002 (1): 241–262.
https://doi.org/10.1182/asheducation-2002.1.241
Published: 2002